Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 373

1.

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.

Ann Rheum Dis. 2016 Nov 24. pii: annrheumdis-2016-209519. doi: 10.1136/annrheumdis-2016-209519. [Epub ahead of print]

PMID:
27884822
2.

Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.

Dörner T, Lipsky PE.

Nat Rev Rheumatol. 2016 Nov;12(11):645-657. doi: 10.1038/nrrheum.2016.158. Review.

PMID:
27733759
3.

The Vienna Declaration on Public Health.

McKee M, Stuckler D, Zeegers Paget D, Dorner T.

Eur J Public Health. 2016 Oct 15. pii: ckw194. [Epub ahead of print] No abstract available.

PMID:
27744344
4.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163.

5.

Fear of falling reduced by a lay led home-based program in frail community-dwelling older adults: A randomised controlled trial.

Kapan A, Luger E, Haider S, Titze S, Schindler K, Lackinger C, Dorner TE.

Arch Gerontol Geriatr. 2017 Jan - Feb;68:25-32. doi: 10.1016/j.archger.2016.08.009.

PMID:
27588891
6.

Association between Nutritional Status and Quality of Life in (Pre)frail Community-dwelling Older Persons.

Luger E, Haider S, Kapan A, Schindler K, Lackinger C, Dorner TE.

J Frailty Aging. 2016;5(3):141-8. doi: 10.14283/jfa.2016.88.

PMID:
27554313
7.

[Therapy-resistant cells of the B cell line].

Hoyer BF, Dörner T.

Z Rheumatol. 2016 Aug;75(6):556-9. doi: 10.1007/s00393-016-0126-y. German. No abstract available.

PMID:
27379736
8.
9.

Effects of a Home-Based and Volunteer-Administered Physical Training, Nutritional, and Social Support Program on Malnutrition and Frailty in Older Persons: A Randomized Controlled Trial.

Luger E, Dorner TE, Haider S, Kapan A, Lackinger C, Schindler K.

J Am Med Dir Assoc. 2016 Jul 1;17(7):671.e9-671.e16. doi: 10.1016/j.jamda.2016.04.018.

PMID:
27346650
10.

Individual Cognitive Social Capital and Its Relationship with Pain and Sick Leave Due to Pain in the Austrian Population.

Muckenhuber J, Pollak L, Stein KV, Dorner TE.

PLoS One. 2016 Jun 20;11(6):e0157909. doi: 10.1371/journal.pone.0157909.

11.

Toward new criteria for systemic lupus erythematosus-a standpoint.

Aringer M, Dörner T, Leuchten N, Johnson SR.

Lupus. 2016 Jul;25(8):805-11. doi: 10.1177/0961203316644338.

PMID:
27252256
12.

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.

Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, Gottenberg JE, Theander E, Tzioufas A, De Vita S, Ramos-Casals M, Dörner T, Quartuccio L, Ravaud P, Mariette X; EULAR Sjögren Task Force..

Ann Rheum Dis. 2016 Nov;75(11):1945-1950. doi: 10.1136/annrheumdis-2015-208504.

PMID:
27150113
13.

The Prevalence of Dental Implants and Related Factors in Patients with Sjögren Syndrome: Results from a Cohort Study.

Albrecht K, Callhoff J, Westhoff G, Dietrich T, Dörner T, Zink A.

J Rheumatol. 2016 Jul;43(7):1380-5. doi: 10.3899/jrheum.151167.

PMID:
27134257
14.

Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor.

Lumb S, Fleischer SJ, Wiedemann A, Daridon C, Maloney A, Shock A, Dörner T.

J Cell Commun Signal. 2016 Jun;10(2):143-51. doi: 10.1007/s12079-016-0322-1.

15.

[Laboratory diagnostics in rheumatology].

Dörner T, Fleck M.

Z Rheumatol. 2016 May;75(4):354-5. doi: 10.1007/s00393-016-0087-1. German. No abstract available.

PMID:
27115696
16.
17.
18.

Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.

Sunderkötter C, Nast A, Worm M, Dengler R, Dörner T, Ganter H, Hohlfeld R, Melms A, Melzer N, Rösler K, Schmidt J, Sinnreich M, Walter MC, Wanschitz J, Wiendl H.

J Dtsch Dermatol Ges. 2016 Mar;14(3):321-38. doi: 10.1111/ddg.12909.

PMID:
26972210
19.

The changing landscape of biosimilars in rheumatology.

Dörner T, Strand V, Cornes P, Gonçalves J, Gulácsi L, Kay J, Kvien TK, Smolen J, Tanaka Y, Burmester GR.

Ann Rheum Dis. 2016 Jun;75(6):974-82. doi: 10.1136/annrheumdis-2016-209166. Review.

20.

Prevalence and Correlates of Smoking and Readiness to Quit Smoking in People Living with HIV in Austria and Germany.

Brath H, Grabovac I, Schalk H, Degen O, Dorner TE.

PLoS One. 2016 Feb 26;11(2):e0150553. doi: 10.1371/journal.pone.0150553.

Items per page

Supplemental Content

Loading ...
Support Center